Ahead of the Bell: Pluristem Therapeutics climbs
Ahead of the Bell: Pluristem Therapeutics climbs. Pluristem Therapeutics climbed sharply in premarket trading Monday after the Israeli drugmaker said a cancer patient's life was saved with the use of its Placental Expanded cells. The company said the ...
Pluristem stem cells save second patient with bone marrow failureFox News
Equity Briefing: Pluristem's PLX Cell Therapy in Failed Bone Marrow Transplant ...Reuters
Pluristem Receives Approval to Commence a Phase I/II Study for Muscle ...NASDAQ
FierceBiotech -Equities.com -Pharmaceutical Business Review
all 61 news articles »